Novel malabsorption panel speeds diagnosis
Answers from the Lab
Timely diagnosis is key for children with chronic diarrhea or unexplained weight loss. In this test specific episode of the "Answers From the Lab" podcast, Puanani Hopson, D.O., explains how Mayo Clinic Laboratories’ novel malabsorption panel combines four existing tests to yield faster results from a single stool sample.
"Our panel can narrow down the differential diagnosis swiftly and easily," Dr. Hopson says. "Stool testing for children can be quite cumbersome. Performing all four tests in one setting is going to help patients and clinicians."
The panel combines the laboratory's existing pancreatic elastase, calprotectin, reducing substance and alpha-1-antitrypsin tests. It's the only existing panel that allows all four tests to be run at the same time with a single specimen.
Listen to learn more about Mayo Clinic Laboratories' pediatric malabsorption panel.
Note: Podcasts will not playback on Internet Explorer. Please use an alternative web browser, or listen from your mobile device on a preferred listening app.
Container/Tube: Stool container
Specimen Volume: 18 g split between 2 containers, each containing half of the specimen
Analytic time: 4 to 6 days
Days performed: Monday through Friday
Lisa Rimsza, M.D., explains how Mayo Clinic Laboratories' unique PM3CX test can accurately determine subtypes of large B-cell lymphoma. Precise diagnosis is critical to choosing appropriate chemotherapy.
Patients with elevated LDL or "bad" cholesterol face even greater risk if their levels of small dense LDL cholesterol are also high. Vlad Vasile, M.D., Ph.D., and Leslie Donato, Ph.D., explain how Mayo Clinic Laboratories' sdLDL-c assay measures concentrations of the small dense LDL subtype, to better guide clinical care.
Identifying a precise genetic cause of hearing loss impacts clinical management. Nicole Boczek, Ph.D., and Melanie Meyer, M.S., CGC, explain how Mayo Clinic Laboratories' updated panel yields comprehensive results for optimal patient care.